Assessment and Treatment Follow-up
Entering a ketamine or Spravato program requires a comprehensive psychiatric and medical assessment to determine if the treatment is appropriate for your specific health background. Treatment protocols typically involve multiple appointments clustered over several weeks, followed by periodic maintenance sessions. Strict adherence to this schedule is essential for achieving the intended clinical outcomes. In-person clinical observation is mandatory for safety.
Telehealth may be used for assessments or follow-up, but it does not establish that a clinic offers home treatment. Spravato must be administered in a certified healthcare setting with at least two hours of observation. Some clinicians prescribe other ketamine formulations off-label for home use; those products are not FDA-approved for psychiatric treatment, and the FDA warns about compounded ketamine risks, especially without on-site monitoring. Confirm the formulation, setting and safety plan with the prescriber; never assume infusion or Spravato services are offered remotely.
Monitoring and Safe Transportation
For safety reasons, medications like Spravato must be administered exclusively in a certified healthcare setting. Following the administration of the dose, patients must undergo at least two hours of continuous clinical monitoring to watch for potential side effects such as sedation or dissociation. After this observation period, patients are strictly prohibited from driving or operating heavy machinery until the next day after a restful sleep. A responsible adult must be arranged to drive you back to your Gilbert home, which is especially important during the intense summer heat when dehydration can exacerbate fatigue. If you or a loved one are facing a mental health emergency, immediately contact the Arizona statewide crisis line at 1-844-534-4673 (available 24/7) or dial 988.